DENT NEUROSCIENCES RESEARCH CENTER INC

EIN: 161583617 501(c)(3) Medical Research

AMHERST, NY

Total Revenue
$2,796,179
Total Expenses
$2,734,965
Total Assets
$4,559,033
Net Assets
$4,033,684
🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Sign In — Free (10 views/day)

Financial Trends

Organization Details

Formation Year
2000
Legal Domicile
NY
Principal Officer
MICHELLE RAINKA PHARMD
Phone
7162502000
Tax Period
2023-01-01 to 2023-12-31

DENT NEUROSCIENCES RESEARCH CENTER INC, founded in 2000, is a community nonprofit in the Medical Research sector that reported $2.8M in total revenue in fiscal year 2023. Revenue grew 9% year-over-year, indicating healthy expansion.

Mission

TO CONDUCT SCIENTIFIC RESEARCH IN THE PUBLIC INTEREST.

Program Service Accomplishments

Program 1
Expenses: $2,687,168 Revenue: $2,452,024

CONDUCTED SCIENTIFIC RESEARCH IN THE PUBLIC INTEREST; SPECIFICALLY, CONDUCTED ORIGINAL INVESTIGATION IN THE MEDICAL SPECIALTY OF NEUROSCIENCE. THE RESULTS OF SUCH RESEARCH WILL BE MADE AVAILABLE TO...

Read more

CONDUCTED SCIENTIFIC RESEARCH IN THE PUBLIC INTEREST; SPECIFICALLY, CONDUCTED ORIGINAL INVESTIGATION IN THE MEDICAL SPECIALTY OF NEUROSCIENCE. THE RESULTS OF SUCH RESEARCH WILL BE MADE AVAILABLE TO RESEARCHERS OF THE MEDICAL PROFESSION AND THE GENERAL PUBLIC. 26 NEW RESEARCH STUDIES WERE INITIATED IN 2023. RESULTS OF NUMEROUS RESEARCH INITIATIVES WERE PUBLISHED. SEVERAL ADDITIONAL DENT PROVIDERS HAVE BEGUN TO WORK ON RESEARCH INITIATIVES THIS YEAR AS WELL.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Sign In — Free (10 views/day)

Financial Overview (2023)

Revenue Breakdown

Contributions & Grants $266,667
Program Service Revenue $2,452,024
Investment Income $77,488
Other Revenue $0
TOTAL REVENUE $2,796,179

Expense Breakdown

Grants Paid $0
Salaries & Benefits $0
Fundraising Expenses $0
Program Expenses $2,687,168
Other Expenses $2,734,965
TOTAL EXPENSES $2,734,965

Year-over-Year Comparison

2023 2022 Change
Revenue $2,796,179 $2,556,784 +0.1%
Expenses $2,734,965 $2,526,374 +0.1%
Net Income $61,214 $30,410 +1.0%
Key Indicators
✗ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✓ Schedule B Required
🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Sign In

Governance

Voting Members
7
Independent Members
5
Employees
N/A
Volunteers
7

Governance Policies

✓ Conflict of Interest Policy
✗ Whistleblower Policy
✗ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School
✗ Operated a Hospital
✗ Provided First Class Travel
⚠ Reported Conflict of Interest
✗ Reported Asset Diversion
✗ Excess Benefit Transaction
✗ Made Political Expenditures
✗ Engaged in Lobbying
✗ Operated Donor Advised Fund
✗ Maintained Art Collections
✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers
5
$358,994
Total Directors
7
$358,994
Key Employees
0
$0
Highest Compensated
0
reported
Name Title Hours/Week Role Reportable Comp Other Comp Total
JOSEPH V FRITZ PHD TO 123123 BOARD MEMBER/CHIEF ADMIN OFFICER 4.00
Officer Director
$0 $0 $0
LASZLO MECHTLER MD BOARD MEMBER/CHIEF MEDICAL OFFICER 4.00
Officer Director
$200,059 $0 $200,059
FRANCIS M GENGO PHARMD BOARD MEMBER/CHIEF SCIENCE 30.00
Officer Director
$0 $0 $0
VERNICE BATES MD BOARD MEMBER AT LARGE 2.00
Director
$0 $0 $0
MICHELLE RAINKA PHARMD BOARD MEMBER/PRESIDENT 30.00
Officer Director
$151,807 $7,128 $158,935
MAUREEN GRIFFIN TOMCZAK BOARD MEMBER AT LARGE 2.00
Director
$0 $0 $0
HARRY DENT III BOARD MEMBER AT LARGE 3.00
Director
$0 $0 $0
EVA HODGE CHIEF FINANCIAL OFFICER 1.00
Officer
$0 $0 $0
Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year Revenue Expenses Assets Net Income
2024 No data No data No data No data
2023 $2,796,179 $2,734,965 $4,559,033 $61,214
2022 $2,556,784 $2,526,374 $4,849,310 $30,410
2021 $2,403,366 $2,144,017 $5,193,271 $259,349
2020 $2,550,448 $2,047,466 $4,710,497 $502,982
2019 $3,152,982 $2,250,501 $4,418,441 $902,481
2018 $1,398,186 $1,747,019 $2,879,308 $-348,833
Explore More Nonprofits
→Top 100 Nonprofits in New York →Largest U.S. Nonprofits →Best Rated Nonprofits →Most Efficient Nonprofits

Compare DENT NEUROSCIENCES RESEARCH CENTER INC with other nonprofits in New York and across the country.

We Value Your Privacy
We use cookies and similar technologies to analyze site traffic and improve your experience. By clicking "Accept All", you consent to our use of cookies for analytics and measurement.